Despite the remarkable scale-up of AIDS treatment and prevention programs in low and middle income countries in recent years, each year two million people die from AIDS (most without ever having received antiretrovirals ART) and 2.7 million are newly infected by HIV.
Published in the Public Library of Science (PLoS) One, "The Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries," is one of the first efforts to look systematically at the expected economic benefits (returns) to large scale investment in AIDS treatment.


